イボ治療薬の世界市場レポート 2025年

イボ治療薬の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.3％で24億米ドルに成長します。予測期間の成長は、HPVの精密医療、レーザー治療の革新、併用療法、デジタルヘルスソリューション、ヘルスケアアクセシビリティへの取り組みに起因しています。予測期間の主な動向には、標的抗ウイルス療法、遺伝子編集研究、生分解性送達システム、精神皮膚科学への注目などがあります。

イボ治療薬市場は、イボに対するワクチン接種がますます重視されるようになっていることから、成長が見込まれます。ワクチン接種は、感染症、特にヒトパピローマウイルス（HPV）によって引き起こされるイボに対する抗体を開発するためにワクチンを導入することを含みます。HPVに対する治療的または予防的ワクチンは、イボの形成を予防する上で重要な役割を担っています。2023年7月に世界保健機関（WHO）が報告したように、予防接種に重点を置いた結果、接種ゼロの子どもが2021年の1,810万人から2022年には1,430万人に減少するという良好な傾向を示しています。さらに、女児におけるHPVワクチンの初回接種の世界のカバー率は、2021年の16%から2022年には21%に増加し、イボ治療薬市場の成長を促進しています。

ヘルスケアサービスへのアクセスの向上は、イボ治療薬市場の今後の成長を促進すると予想されます。ヘルスケアサービスには、健康の維持・増進を目的とした医療、治療、サポートの提供が含まれます。イボ治療薬は、ヒトパピローマウイルス（HPV）によって引き起こされる一般的な皮膚疾患に対処・治療するために、こうしたサービスの中で利用されています。これらの治療は、症状を緩和し、治癒を促進し、イボの広がりを防ぐことで、全体的な幸福を高めるのに役立ちます。例えば、2023年12月、米国の連邦政府機関であるメディケア＆メディケイド・サービスセンターは、州および地方政府の医療費が2021年の6.2％増に加え、2022年には6.5％増になったと報告しました。さらに、米国のヘルスケア支出は2022年に4.1％増の4兆5,000億米ドルとなり、2021年の3.2％増を上回った。このように、ヘルスケアサービスの利用しやすさの向上が、イボ治療薬市場の拡大を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界イボ治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のイボ治療薬市場：成長率分析
• 世界のイボ治療薬市場の実績：規模と成長, 2019-2024
• 世界のイボ治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界イボ治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のイボ治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一般的なイボ
• 性器イボ
• 扁平イボ
• その他のタイプ
• 世界のイボ治療薬市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 物理的破壊
• 免疫調節
• 化学的な破壊
• 世界のイボ治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界のイボ治療薬市場、一般的な疣贅の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 典型的には手、指、肘に現れる
• ヒトパピローマウイルス（HPV）2型および4型によって引き起こされる
• 世界のイボ治療薬市場性器イボの種類別の分類、実績と予測, 2019-2024, 2024-2029F, 2034F
• 性器と肛門の領域に発生する
• 主にHPV6型と11型によって引き起こされる
• 世界のイボ治療薬市場扁平疣贅の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一般的なイボよりも小さく滑らか
• 顔、首、腕によく見られる
• 世界のイボ治療薬市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 足底疣贅（足）と糸状疣贅（口と鼻の周り）が含まれます
• さまざまなHPV型がこれらのイボを引き起こす可能性がある

第7章 地域別・国別分析

• 世界のイボ治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のイボ治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• イボ治療薬市場：競合情勢
• イボ治療薬市場：企業プロファイル
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Verrica Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cipla Inc.
• Prestige Consumer Healthcare Inc.
• Maruho Co. Ltd
• Taro Pharmaceutical Industries Ltd
• Aclaris Therapeutics Inc.
• Novan Inc
• Scholl's Wellness Co
• AIM ImmunoTech Inc.
• Euro Vital Pharma GmbH
• Koninklijke Utermohlen NV
• Nielsen BioSciences Inc.
• RXi Pharmaceuticals
• Phio Pharmaceuticals Corp.
• MedCara Pharmaceuticals
• KinoPharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• イボ治療薬市場2029：新たな機会を提供する国
• イボ治療薬市場2029：新たな機会を提供するセグメント
• イボ治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Wart therapeutics refer to medical drugs and treatments designed to exert therapeutic effects in addressing the skin condition known as warts, caused by the human papillomavirus (HPV). These therapeutics are utilized for the treatment of various wart types affecting the hands, face, and feet.

The primary types of warts in wart therapeutics include common warts, genital warts, flat warts, and others. Common warts are small, raised skin growths typically found on the hands or fingers. Treatment approaches for common warts involve physical destruction, immunomodulation, and chemical destruction. Wart therapeutics are employed in diverse healthcare settings, including hospitals, homecare, specialty clinics, and others.

The warts therapeutics market research report is one of a series of new reports from The Business Research Company that provides warts therapeutics market statistics, including the warts therapeutics industry global market size, regional shares, competitors with an warts therapeutics market share, detailed warts therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the warts therapeutics industry. This warts therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The warts therapeutics market size has grown steadily in recent years. It will grow from $1.96 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to salicylic acid use, cryotherapy development, topical treatment evolution, surgical interventions, the emergence of immunotherapy

The warts therapeutics market size is expected to see steady growth in the next few years. It will grow to $2.4 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to precision medicine for HPV, laser therapy innovations, combination therapies, digital health solutions, and healthcare accessibility initiatives. Major trends in the forecast period include targeted antiviral therapies, gene editing research, biodegradable delivery systems, psychodermatology focus.

The wart therapeutics market is anticipated to experience growth, driven by the increasing emphasis on vaccinations for warts. Vaccination involves introducing a vaccine to develop antibodies against infections, particularly warts caused by the human papillomavirus (HPV). Therapeutic or prophylactic vaccines against HPV play a crucial role in preventing wart formation. The focus on vaccinations has led to a positive trend, as reported by the World Health Organization in July 2023, indicating a reduction in zero-dose children from 18.1 million in 2021 to 14.3 million in 2022. Furthermore, global coverage for the initial dose of the HPV vaccine in girls increased from 16% in 2021 to 21% in 2022, driving the growth of the wart therapeutics market.

The increasing accessibility of healthcare services is anticipated to drive the growth of the wart therapeutics market in the future. Healthcare services involve the provision of medical care, treatment, and support to individuals aimed at maintaining or improving their health. Wart therapeutics are utilized within these services to address and treat common skin conditions caused by the human papillomavirus (HPV). These treatments help alleviate symptoms, promote healing, and prevent the spread of warts, thereby enhancing overall well-being. For example, in December 2023, the Centers for Medicare & Medicaid Services, a US-based federal agency, reported that state and local government healthcare expenditures increased by 6.5% in 2022, building on a 6.2% rise in 2021. Furthermore, U.S. healthcare spending grew by 4.1% to $4.5 trillion in 2022, surpassing the 3.2% increase recorded in 2021. Thus, the growing accessibility of healthcare services is driving the expansion of the wart therapeutics market.

A significant trend in the wart therapeutics market is the focus on product innovation by companies striving to maintain a competitive edge. Verrica Pharmaceuticals Inc., a US-based dermatology therapeutics company, exemplifies this trend with its announcement in February 2023. The FDA accepted the resubmitted New Drug Application (NDA) for VP-102, a drug-device combination product delivering cantharidin for precise topical dosing and targeted administration to treat molluscum contagiosum, a type of wart.

Major companies in the wart therapeutics market are engaging in strategic partnerships to support clinical trials and advance research. Vial, a US-based pharmaceuticals company, partnered with Nielsen BioSciences Inc. in June 2023 to study the safety and efficacy of CANDIN for treating common warts. This collaborative approach aims to contribute to the development of new therapies and devices for wart treatment.

In March 2022, Novan Inc., a US-based pharmaceutical company, acquired EPI Health for $27.5 million. This acquisition allows Novan Inc. to improve its commercial capabilities in dermatology, broaden its product portfolio, and expedite the development of innovative skin therapies. EPI Health Inc. is a US-based company dedicated to developing innovative wart therapeutics and skincare solutions.

Major companies operating in the warts therapeutics market include GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd, Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Novan Inc, Scholl's Wellness Co, AIM ImmunoTech Inc., Euro Vital Pharma GmbH, Koninklijke Utermohlen NV, Nielsen BioSciences Inc., RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, KinoPharma Inc., pHion Therapeutics, Compound W, Duofilm, Curad Mediplast, Emblation Ltd.

North America was the largest region in the warts therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the warts therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The warts therapeutics market consists of sales of therapeutic drugs such as 5-fluorouracil, benzalkonium, glutaraldehyde, cryotherapy, or podophyllin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Warts Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on warts therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for warts therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The warts therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Common Warts; Genital Warts; Flat Warts; Other Types
• 2) By Treatment: Physical Destruction; Immunomodulation; Chemical Destruction
• 3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows; Caused By Human Papillomavirus (HPV) Types 2 And 4
• 2) By Genital Warts: Occur In The Genital And Anal Areas; Primarily Caused By HPV Types 6 And 11
• 3) By Flat Warts: Smaller And Smoother Than Common Warts; Commonly Found On The Face, Neck, And Arms
• 4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose); Various HPV Types Can Cause These Warts
• Companies Mentioned: GlaxoSmithKline plc; Merck & Co. Inc.; Verrica Pharmaceuticals Inc.; Bausch Health Companies Inc.; Dr. Reddy's Laboratories Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Warts Therapeutics Market Characteristics

3. Warts Therapeutics Market Trends And Strategies

4. Warts Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Warts Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Warts Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Warts Therapeutics Market Growth Rate Analysis
• 5.4. Global Warts Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Warts Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Warts Therapeutics Total Addressable Market (TAM)

6. Warts Therapeutics Market Segmentation

• 6.1. Global Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Common Warts
• Genital Warts
• Flat Warts
• Other Types
• 6.2. Global Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Destruction
• Immunomodulation
• Chemical Destruction
• 6.3. Global Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.4. Global Warts Therapeutics Market, Sub-Segmentation Of Common Warts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Typically Appear On Hands, Fingers, And Elbows
• Caused By Human Papillomavirus (HPV) Types 2 And 4
• 6.5. Global Warts Therapeutics Market, Sub-Segmentation Of Genital Warts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Occur In The Genital And Anal Areas
• Primarily Caused By HPV Types 6 And 11
• 6.6. Global Warts Therapeutics Market, Sub-Segmentation Of Flat Warts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Smaller And Smoother Than Common Warts
• Commonly Found On The Face, Neck, And Arms
• 6.7. Global Warts Therapeutics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose)
• Various HPV Types Can Cause These Warts

7. Warts Therapeutics Market Regional And Country Analysis

• 7.1. Global Warts Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Warts Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Warts Therapeutics Market

• 8.1. Asia-Pacific Warts Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Warts Therapeutics Market

• 9.1. China Warts Therapeutics Market Overview
• 9.2. China Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Warts Therapeutics Market

• 10.1. India Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Warts Therapeutics Market

• 11.1. Japan Warts Therapeutics Market Overview
• 11.2. Japan Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Warts Therapeutics Market

• 12.1. Australia Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Warts Therapeutics Market

• 13.1. Indonesia Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Warts Therapeutics Market

• 14.1. South Korea Warts Therapeutics Market Overview
• 14.2. South Korea Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Warts Therapeutics Market

• 15.1. Western Europe Warts Therapeutics Market Overview
• 15.2. Western Europe Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Warts Therapeutics Market

• 16.1. UK Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Warts Therapeutics Market

• 17.1. Germany Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Warts Therapeutics Market

• 18.1. France Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Warts Therapeutics Market

• 19.1. Italy Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Warts Therapeutics Market

• 20.1. Spain Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Warts Therapeutics Market

• 21.1. Eastern Europe Warts Therapeutics Market Overview
• 21.2. Eastern Europe Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Warts Therapeutics Market

• 22.1. Russia Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Warts Therapeutics Market

• 23.1. North America Warts Therapeutics Market Overview
• 23.2. North America Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Warts Therapeutics Market

• 24.1. USA Warts Therapeutics Market Overview
• 24.2. USA Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Warts Therapeutics Market

• 25.1. Canada Warts Therapeutics Market Overview
• 25.2. Canada Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Warts Therapeutics Market

• 26.1. South America Warts Therapeutics Market Overview
• 26.2. South America Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Warts Therapeutics Market

• 27.1. Brazil Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Warts Therapeutics Market

• 28.1. Middle East Warts Therapeutics Market Overview
• 28.2. Middle East Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Warts Therapeutics Market

• 29.1. Africa Warts Therapeutics Market Overview
• 29.2. Africa Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Warts Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Warts Therapeutics Market Competitive Landscape
• 30.2. Warts Therapeutics Market Company Profiles
  • 30.2.1. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Verrica Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Dr. Reddy's Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Warts Therapeutics Market Other Major And Innovative Companies

• 31.1. Cipla Inc.
• 31.2. Prestige Consumer Healthcare Inc.
• 31.3. Maruho Co. Ltd
• 31.4. Taro Pharmaceutical Industries Ltd
• 31.5. Aclaris Therapeutics Inc.
• 31.6. Novan Inc
• 31.7. Scholl's Wellness Co
• 31.8. AIM ImmunoTech Inc.
• 31.9. Euro Vital Pharma GmbH
• 31.10. Koninklijke Utermohlen NV
• 31.11. Nielsen BioSciences Inc.
• 31.12. RXi Pharmaceuticals
• 31.13. Phio Pharmaceuticals Corp.
• 31.14. MedCara Pharmaceuticals
• 31.15. KinoPharma Inc.

32. Global Warts Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Warts Therapeutics Market

34. Recent Developments In The Warts Therapeutics Market

35. Warts Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Warts Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Warts Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Warts Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer